Cannabidiol with clobazam
Red
Brand:
Nice TA:
615
Commissioning responsibility:
NHS England
PbR excluded:
No
BNF chapter:
Central nervous system
Background
1.1 Cannabidiol with clobazam is recommended as an option for treating seizures associated with Lennox–Gastaut syndrome in people aged 2 years and older, only if:
• the frequency of drop seizures is checked every 6 months, and cannabidiol is stopped if the frequency has not fallen by at least 30% compared with the 6 months before starting treatment
• the company provides cannabidiol according to the commercial arrangement.
Recommendation
LSCMMG Recommendation:
Red
Reason for decision:
Specialist medicine
Supporting documents: